Fennec Pharmaceuticals (FENC) Research & Development (2010 - 2026)
Fennec Pharmaceuticals' Research & Development was $118,000 in Q2 2026, up 10.3% from $107,000 a year earlier.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Research & Development (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Fennec Pharmaceuticals' Research & Development was $274,000 through Jun 30, 2026, down 21.3% year-over-year; for FY2025, it was $250,000, down 18.6% from FY2024.
- Research & Development shows a five-year compound annual growth rate of -45.3% (FY2020 to FY2025).
- In earlier years, Research & Development was $307,000 in FY2024 (+448.2%), $56,000 in FY2023 (-98.4%), $3.53 million in FY2022 (-29.1%) and $4.98 million in FY2021 (-2.4%).
- The Q2 2026 figure marks the highest quarterly Research & Development since Q2 2024.
- Compared with a year earlier, Research & Development was higher in three of the last six quarters, with growth averaging 102.2%.
- The best year-over-year quarter for Research & Development over five years was Q3 2024 (growth of 708.3%); the worst was Q1 2023 (a decline of 99.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Fennec Pharmaceuticals | 383.62 Mn | 264.93 Mn | 17.15 Mn | 118,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 118,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 107,000.00 |
| Mar 31, 2025 | 94,000.00 |
| Dec 31, 2024 | 50,000.00 |
| Sep 30, 2024 | 97,000.00 |
| Jun 30, 2024 | 157,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 117,000.00 |
| Sep 30, 2022 | 846,000.00 |
| Jun 30, 2022 | 1.13 Mn |
| Mar 31, 2022 | 1.44 Mn |
| Dec 31, 2021 | 523,000.00 |
| Sep 30, 2021 | 1.24 Mn |
| Jun 30, 2021 | 800,000.00 |
API Access
Fennec Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=FENC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "FENC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=FENC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();